Table 2.
Trichomonas vaginalis seropositive status and diagnosis of aggressive prostate cancer
| Diagnosis of aggressive PCa | ||||
|---|---|---|---|---|
| Gleason < 7 | Gleason ≥ 7 | OR | 95 % CI | |
| n | 74 | 101 | ||
| Mean (SD) | 0.25 (0.10) | 0.26 (0.10) | ||
| Serostatus | ||||
| Negative | 60 (81.1 %) | 80 (79.2 %) | ||
| Positive | 14 (18.9 %) | 21 (20.8 %) | 1.04 | 0.48–2.26 |
| Stage 0–1 | Stage 2–4 | |||
|---|---|---|---|---|
| n | 230 | 40 | ||
| Mean (SD) | 0.25 (0.12) | 0.26 (0.10) | ||
| Serostatus | ||||
| Negative | 179 (77.8 %) | 30 (75.0 %) | ||
| Positive | 51 (22.2 %) | 10 (25.0 %) | 1.23 | 0.55–2.74 |
Stage and grade data were not provided by every tumor registry
aAdjusted for age at diagnosis, race, and income